FDA Holds Zydus Cadila Responsible For ‘Repeat Violations’

Agency May Withhold Approval Of Abbreviated New Drug Applications

 
• By Akriti Seth
  
Unhappy and disappointed customer giving low rating and negative feedback in survey, poll or questionnaire. Sad and dissatisfied man giving review about service quality. Bad user experience. - Image
FDA releases details of the warning letter sent to Zydus Cadila • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Business